Dapagliflozin + Metformin is a combination antidiabetic medicine used to manage Type 2 Diabetes Mellitus in adults. It helps lower blood sugar levels by improving insulin efficiency and promoting glucose loss through urine. This dual-acting therapy is commonly prescribed when metformin alone is insufficient to achieve glycaemic control. Regular use supports better blood sugar management, weight reduction, and improved overall metabolic health.

Dapagliflozin + Metformin is a widely prescribed combination therapy for adults with Type 2 Diabetes Mellitus. This medicine brings together two effective antidiabetic agents that work through different pathways to achieve optimal blood glucose control. Metformin reduces the production of glucose in the liver and enhances the body’s response to insulin, while dapagliflozin, an SGLT-2 inhibitor, helps remove excess glucose through urine. Together, they deliver stronger and more sustained glycaemic control compared to monotherapy alone.

This combination is particularly beneficial for patients who have not achieved desired blood sugar targets with metformin alone or lifestyle modifications such as diet and exercise. It may also support modest weight loss and help reduce the risk of diabetes-related complications, including nerve damage, kidney problems, and cardiovascular issues. The medicine is generally taken once or twice daily, depending on the formulation and medical advice.

Dapagliflozin + Metformin may also offer additional health benefits, such as lowering blood pressure and improving kidney outcomes in suitable patients. Regular monitoring of kidney function, blood sugar levels, and overall health is recommended throughout treatment. This medicine should always be taken under medical supervision, as dosage adjustments may be required based on kidney health, age, and associated medical conditions.

• Helps control blood sugar levels in adults with Type 2 Diabetes Mellitus.

• Prescribed when metformin alone does not provide adequate glycaemic control.

• Supports weight reduction by promoting glucose excretion.

• Helps reduce the risk of diabetes-related long-term complications.

• Improves insulin sensitivity and lowers hepatic glucose production.

• May lower blood pressure and benefit kidney health in appropriate patients.

• Can be used as part of a comprehensive diabetes management plan including diet and exercise.

Dapagliflozin + Metformin provides combined benefits for better diabetes management. The dual mechanism of action offers more effective glycaemic control compared to individual therapy. Patients may experience improved fasting and post-meal blood sugar levels within weeks of regular use. The dapagliflozin component helps eliminate glucose through urine, contributing to modest weight loss, an added benefit for overweight individuals. Metformin enhances the body’s insulin response and reduces glucose production in the liver, further supporting blood sugar balance. Together, they help reduce the risk of long-term complications such as nerve damage, kidney issues, heart disease, and poor circulation.

• Frequent urination

• Genital fungal infections

• Urinary tract infections

• Nausea or vomiting

• Stomach discomfort or diarrhoea

• Headache

• Low blood sugar (especially when combined with other antidiabetic medicines)

• Dehydration or dizziness

• Metallic taste

• Rarely: lactic acidosis (metformin-related), ketoacidosis (dapagliflozin-related)

• Take medicine with meals to reduce stomach upset.

• Swallow the tablet whole with water; do not crush or chew.

• Follow your doctor’s dosing schedule carefully, usually once or twice daily.

• Maintain a consistent time every day for best results.

• Continue lifestyle modifications such as diet and exercise alongside medication.

• Never change the dose without medical advice.

Dapagliflozin works by inhibiting the Sodium-Glucose Co-Transporter 2 (SGLT-2) protein in the kidneys. This action prevents glucose reabsorption, allowing excess sugar to be eliminated through urine, thereby lowering blood glucose levels. It also assists in weight control and may moderately lower blood pressure. Metformin acts primarily by reducing hepatic glucose production and improving peripheral insulin sensitivity. It decreases glucose absorption in the intestine and enhances the body’s utilisation of insulin. Together, these actions produce comprehensive glycaemic control in adults with Type 2 Diabetes Mellitus. The combination reduces both fasting and post-meal glucose levels, offering a balanced and effective approach to diabetes management.

• Stay hydrated to reduce the risk of dehydration and urinary infections.

• Maintain good genital hygiene to prevent fungal infections.

• Monitor blood sugar regularly and keep track of readings.

• Avoid skipping meals to prevent low blood sugar.

• Report symptoms like stomach pain, rapid breathing, or extreme fatigue immediately.

• Store at room temperature below 25°C.

• Keep away from moisture and direct sunlight.

• Do not freeze.

• Keep out of reach of children and pets.

• Dispose of expired tablets safely; do not flush into wastewater.

This medicine generally has no significant interactions with common foods, but it should be taken with meals to minimise stomach discomfort caused by metformin. Avoid excessive alcohol intake, which increases the risk of lactic acidosis. Maintaining proper hydration is important, as dapagliflozin increases urine output.

Avoid:

• Heavy alcohol consumption

• Very low-calorie diets without medical guidance

• Dehydrating beverages if taken in excess (high-caffeine drinks)

This combination may interact with several medicines that affect blood sugar levels or kidney function. Concomitant use with insulin or sulfonylureas may increase the risk of hypoglycaemia. Diuretics may increase the risk of dehydration. Certain blood pressure medicines may require dose adjustments.

Use caution with:

• Insulin or insulin secretagogues

• Diuretics

• ACE inhibitors or ARBs

• NSAIDs

• Steroids

• Thyroid hormone medications

Dapagliflozin + Metformin should be used cautiously in certain medical conditions. Metformin is contraindicated in severe kidney or liver disease due to the risk of lactic acidosis. Dapagliflozin should be avoided in recurrent urinary tract infections, dehydration, or ketoacidosis risk.

Use with caution in:

• Kidney impairment

• Liver disease

• Heart failure

• Dehydration or low blood pressure

• Recurrent genital infections

• Pancreatic disorders

Take the dose exactly as prescribed by your doctor, usually once or twice daily with meals. The exact dose may vary depending on your blood sugar levels, kidney function, and treatment goals. Do not modify the dose without medical supervision.

Taking more than the prescribed dose may lead to severe low blood sugar, dehydration, lactic acidosis, or ketoacidosis. Symptoms may include rapid breathing, confusion, stomach pain, or fainting. Seek emergency medical help immediately. Do not wait for symptoms to worsen.

If you forget a dose, take it as soon as you remember. If it is nearly time for your next dose, skip the missed one and continue with your regular schedule. Do not take two doses together to make up for the missed dose. Missing doses frequently may affect blood sugar control, so try to take the medicine consistently. If unsure, consult your doctor for guidance.